It’s Super Bowl week! Over the years, we’ve written occasionally about marijuana issues and the National Football League. See here, here, and here, for example. As more states legalize marijuana, its prevalence in NFL cities is only increasing. This year, the Super Bowl will be in my backyard in Los Angeles (GO RAMS!), and I have

The post The NFL and Medical Marijuana appeared first on Harris Bricken.

Both research groups that are receiving research funding from the NFL will be focusing on how cannabinoids can help with pain management and other football-related ailments.

The post NFL Awards $1 Million to Two Cannabis Research Initiatives appeared first on High Times.

Dementia steals the ability of the brain to function optimally. It takes away all hope that the sufferers can live everyday life. It can be acute or chronic, but the senior will become a shadow of himself in the end. This is why there are still many ongoing studies on what CBD can do for these seniors who have Dementia. Meanwhile, studies have shown that CBD can help preserve or slow down and even restore neurological functions lost to dementia.

Is CBN Going To Give Melatonin A Run For Its Money?

The cannabinoid CBN is going to change the sleeping game going forward.

The post Is CBN Going To Give Melatonin A Run For Its Money? appeared first on The Fresh Toast.

Tuesday, January 18, 2022 Aristotle, Confucius, Voltaire, and Shakespeare – each of them famously cautioned, in some fashion and in his own language, that perfect is the enemy of good. While we should strive for the best result, if the best result is not attainable, we shouldn’t forego a good result to end up with […]

Since 1971, a single facility at the University of Mississippi has been in charge of producing cannabis plants for research purposes at the federal level. This monopoly prevented other facilities (public and private-owned) from growing marijuana for experimental reasons. In 2016, the DEA began to remove the monopoly on marijuana for medical research. Finally, they achieved what they set out to do in May 2021. The applications of several cannabis companies were approved by mid-2021. Groff Hemplex and the Biopharmaceutical Research Company revealed that they have been fully registered in the DEA database and have started cultivating cannabis plants. The first phase of harvest, which started about a month ago, will be forwarded to research facilities. Marijuana researchers across the country have commended this development.

After over 50 years of a monopoly for the cultivation of cannabis for research purposes, the DEA is ending the University of Mississippi’s...

The United States cannabis market is the largest in the world with sales expected to surpass $92 billion by the end of 2021....

SALT LAKE CITY, UT, March 24, 2021 — OTC PR WIRE — Gaensel Energy Group, Inc., (OTC Pink: GEGR) (“Gaensel” or the...

WASHINGTON, D.C. – Legislation to expand access to cannabis products for clinical research has advanced in the House Energy and Commerce Committee. First...

A House of Representatives committee voted on Wednesday to approve a bill that would allow researchers to conduct studies using marijuana produced in...

The House Committee on Energy and Commerce approved a bill this week that seeks to improve and accelerate research on medical marijuana in...